Richard Ljuhar is CEO and co-founder of Image Biopsy Lab. After finishing his studies at the Technical University Vienna, Richard Ljuhar gained international experience in product development and international marketing at one of the world’s leading medical device companies based in Boston, Massachusetts. Upon returning to Austria to complete his dissertation, Richard joined Vienna-based Braincon Technologies to lead research projects in medical software applications. As part of such projects, Dr. Ljuhar co-founded ImageBiopsy Lab to use advanced image analysis algorithms for the assessment of bone microarchitecture and the overall bone morphology. ImageBiopsy Lab employs by now 25 highly skilled team members from 8 nations at its Vienna-HQ with an overall funding of more than €12M received to date.
ImageBiopsy Lab (IB Lab) is a leading digital health scale-up, providing AI-supported expertise for orthopedic surgery, musculoskeletal (MSK) radiology and affected patients alike. We are a group of physicians, software engineers and entrepreneurs, passionate about our cause to find optimal solutions to complex medical needs through the latest technological innovations. Our vision is to become the One-Stop-Shop for musculoskeletal imaging intelligence, enabling new medical standards for 1.7B patients being affected. What differentiates IB Lab from other AI-supported medical companies is our clear focus to go beyond diagnostics, turning large amounts of unstructured imaging data into meaningful evidence.